PCG
ASND icon

Private Capital Group’s Ascendis Pharma A/S ASND Stock Holding History

Private Capital Group’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-20
Closed -$3K – 2114
2021
Q1 		$3K Buy
+20
New +$3.04K ﹤0.01% 1638

Other funds holding ASND

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Private Capital Group's ASND Position: Q2 2021 in Review

Private Capital Group sold out of Ascendis Pharma A/S (ASND) in Q2 2021, closing a stake of 20 shares — an estimated $3K sold.

Private Capital Group first reported a position in ASND in Q1 2021 and held it in 1 quarter. The position peaked at $3K in Q1 2021. 171 funds tracked by Wall St. Rank hold ASND as of Q2 2021.

  • Private Capital Group reported no remaining Ascendis Pharma A/S position as of Q2 2021 after selling out during the quarter.
  • Private Capital Group sold 20 Ascendis Pharma A/S shares in Q2 2021, an estimated $3K.
  • Private Capital Group first reported a position in Ascendis Pharma A/S in Q1 2021 and held it in 1 quarter.
  • Private Capital Group's Ascendis Pharma A/S position peaked at $3K in Q1 2021.
  • 171 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q2 2021.

Based on Private Capital Group's 13F filing for Q2 2021, filed 26 Jul 2021.